Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

IVC Index in Patient With Diarrhea and Dehydration And How It Affects Its Management

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04654832
Recruitment Status : Recruiting
First Posted : December 4, 2020
Last Update Posted : December 4, 2020
Sponsor:
Information provided by (Responsible Party):
Reham Refaat abd elhafez, Assiut University

Brief Summary:
IVC Index in patient with Diarrhea and Dehydration And How It affects its management.

Condition or disease
Diarrhea, Infantile

Detailed Description:

Introduction The world health organization defines dehydration as condition that result from excessive loss of body water .the most common cause of dehydration in children are vomiting and diarrhea. Dehydration is a major cause of morbidity and mortality in infant and young children world wide .most cases due to consequence of acute gastroenteritis.

Pathophysiology. Dehydration cause decrease in total body water in both intracellular and extracellular fluid volume. Volume depletion closely correlate with sign and symptom of dehydration .the total body water is higher in infant and children compared to adult.

In infant, it is 70% of total body weight, whereas it is 65%and 60% respectively in children and adult.

The World Health Organization recommends assessing dehydration in children based on four clinical features: general appearance , eyes (whether they appear sunken), history of thirst , and skin pinch to assess turgor. However, these clinical signs may be subtle or non specific and thus have important limitations if used as independent predictors of dehydration. A more objective way to assess for dehydration using urine analysis has been implicated.

Additionally, studies on dehydration have shown urine analysis do not show sufficient sensitivity, Specificity or reliability [3, 4] and are typically only useful in children with moderate to severe hypovolemia.

. Bedside ultrasonography is a noninvasive method that can serve as a more objective tool for assessing dehydration in both adults and children. Point-of-care ultrasound has the potential to reduce unnecessary use of resources such as IV fluids or hospital access, while identifying children who are severely dehydrated and need immediate medical attention. Previous studies have shown that intravascular volume correlates to the diameters of the inferior vena cava.

  • The normal IVC diameter is 15_ 17mm
  • small IVC (usually < 12mm) with spontaneous collapse is often seen in the presence of intravascular volume depletion.

Bedside emergency ultrasonography (EUS) is a relatively new imaging modality in pediatrics.(8,9) EUS is fast, painless, and noninvasive. In recent years, many new pediatric indications for EUS have been developed.

Ultrasonography (US) assessment of the inferior vena cava (IVC) has been used as a noninvasive diagnostic tool for the assessment of intravascular volume and right heart function. Specifically, IVC diameter and collapsibility have been used as methods of assessing fluid status in dehydrated patients .

In these studies, contraction of the intravascular volume resulted in measurable decreases in IVC diameters. Conversely, research has shown that the diameter of the descending aorta (Ao) remains mostly constant, despite intravascular volume depletion.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 57 participants
Observational Model: Case-Crossover
Time Perspective: Cross-Sectional
Official Title: IVC Index in Patient With Diarrhea and Dehydration And How It Affects Its Management
Actual Study Start Date : October 1, 2020
Estimated Primary Completion Date : December 29, 2020
Estimated Study Completion Date : December 29, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dehydration Diarrhea




Primary Outcome Measures :
  1. (IVC Index in patient with Diarrhea and Dehydration and how it affects it's management.) [ Time Frame: IVC Index in patient with Diarrhea and Dehydration And How It affects its management21.(13). it expect it expected to be done from 1 October2020 till 29 December2021.(13) ]
    Assessment of dehydration by ivc index and bcmanagement according to this index



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Month to 5 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
*Sample size: According to the G*Power 3 software (Faul et al., 2007); the calculated minimum sample was 57 patient with dehydration needed to detect an effect size of 0.5 in the percentage of weight change after rehydration (12), with an error probability of 0.05 and 95 % power on a two-tailed test, it expected to be done from 1 October2020 till 29 December2021.(13)
Criteria

(Inclusion Criteria):

  • Patients under 5years old who Presented with acute diarrhea and clinical evidence of significant (Moderate and severe) dehydration and sepsis based on blood picture ,high grade fever and CRP
  • Patients under 5 years old with dehydration and non septic condition.
  • Patients under 5years old have cardiomyopathy previously diagnosed.

(Exclusion Criteria ):

  • Patients receiving oral rehydration solution only .
  • chronic medical conditions, bronchopulmonary dysplasia and renal and liver diseases.
  • Children with acute blood loss were also excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04654832


Contacts
Layout table for location contacts
Contact: Reham RR Refaat, Master 01094494643 ryhamrema@yahoo.com

Locations
Layout table for location information
Egypt
Reham Recruiting
Assiut, Egypt
Contact: Elsayed Khalil, Professor    0106 080 5170      
Contact: Duaa Mohammad, Professor    0122 311 2124    Diana.ahmed3@med.au.edu.eg   
Sponsors and Collaborators
Assiut University
Investigators
Layout table for investigator information
Study Director: Elsayed Khalil Abd elkarem, Professor Assiut University
Study Director: Duaa Mohamad raafat, Assistant Assiut University
Layout table for additonal information
Responsible Party: Reham Refaat abd elhafez, Assistant lecturer, Assiut University
ClinicalTrials.gov Identifier: NCT04654832    
Other Study ID Numbers: IVC Index
First Posted: December 4, 2020    Key Record Dates
Last Update Posted: December 4, 2020
Last Verified: December 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Reham Refaat abd elhafez, Assiut University:
IVC Index
Additional relevant MeSH terms:
Layout table for MeSH terms
Dehydration
Diarrhea
Diarrhea, Infantile
Signs and Symptoms, Digestive
Water-Electrolyte Imbalance
Metabolic Diseases
Pathologic Processes